SMLR - Semler Scientific: A Small Company Solving A Big Problem
- Semler Scientific has been sold off since its Q3 and Q4 earnings misses, down 67% from November 2021 levels.
- Semler is tackling massive healthcare problems such as PAD, diabetes, and Alzheimer's.
- Its flagship QuantaFlo product is a fundamentally superior product that tests for PAD with minimal training and cost.
- As a small-cap company that is profitable and growing revenue, I believe Semler is a hidden gem that investors should get their hands on.
- In this article, I will outline why you should take a closer look at Semler Scientific.
For further details see:
Semler Scientific: A Small Company Solving A Big Problem